97170-10-0 Usage
Description
(R)-2-Hydroxyethyl-L-cysteine is a chemical compound derived from the amino acid cysteine, featuring a hydroxyethyl group and a thiol group. It is recognized for its antioxidant properties and its ability to scavenge free radicals, which can help reduce oxidative stress in the body. Furthermore, it has been investigated for its potential protective effects against certain types of toxicity, particularly in the liver and kidneys. This versatile compound holds promise for a range of applications in medicine and biochemistry.
Uses
Used in Pharmaceutical Applications:
(R)-2-Hydroxyethyl-L-cysteine is used as a chelating agent for its ability to bind with metal ions, which can be beneficial in various medical treatments and pharmaceutical formulations.
Used in Antioxidant Formulations:
Given its antioxidant properties, (R)-2-Hydroxyethyl-L-cysteine is used as an additive in the development of antioxidant formulations designed to combat oxidative stress and protect cells from damage.
Used in Medical Research:
(R)-2-Hydroxyethyl-L-cysteine is utilized in medical research as a potential protective agent against liver and kidney toxicity, with ongoing studies to determine its full range of therapeutic applications.
Used in Biochemical Applications:
In the field of biochemistry, (R)-2-Hydroxyethyl-L-cysteine is used as a reagent or a component in various biochemical processes and assays, taking advantage of its unique structural features and functional groups.
Check Digit Verification of cas no
The CAS Registry Mumber 97170-10-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,1,7 and 0 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 97170-10:
(7*9)+(6*7)+(5*1)+(4*7)+(3*0)+(2*1)+(1*0)=140
140 % 10 = 0
So 97170-10-0 is a valid CAS Registry Number.
97170-10-0Relevant articles and documents
Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamates
Levin,Chen,Laakso,Du,Du,Venkatesan,Sandanayaka,Zask,Xu,Xu,Zhang,Skotnicki
, p. 4345 - 4349 (2007/10/03)
The SAR of a series of potent sulfonamide hydroxamate TACE inhibitors bearing a butynyloxy P1′ group was explored. In particular, compound 5k has excellent in vitro potency against TACE enzyme and in cells, and oral activity in an in vivo model of TNF-α production and a collagen-induced arthritis model.
Synthesis of Optically Active 1,4-Thiazane-3-carboxylic Acid via Optical Resolution by Preferential Crystallization of (RS)2-Amino-3-[(2-chloroethyl)sulfanyl]propanoic Acid Hydrochloride
Shiraiwa, Tadashi,Tadokoro, Kohya,Tanaka, Haruyuki,Nanba, Keiichiro,Yokono, Noriyoshi,Shibazaki, Katsuyoshi,Kubo, Motoki,Kurokawa, Hidemoto
, p. 2382 - 2387 (2007/10/03)
Optically active 1,4-thiazane-3-carboxylic acid [TCA] was synthesized from cysteine via optical resolution by preferential crystallization. The intermediate (RS)-2-amino-3-[(2-chloroethyl)sulfanyl]propanoic acid hydrochloride [(RS)-ACS-HCl] was found to exist as a conglomerate based on its melting point, solubility and IR spectrum. (RS)-ACS·HCl was optically resolved by preferential crystallization to yield (R)- and (S)-ACS·HCl. (R)- and (S)-ACS·HCl thus obtained were recrystallized from a mixture of hydrochloric acid and 2-propanol, taking account of the solubility of (RS)-ACS·HCl, efficiently yielding both enantiomers in optically pure forms. (R)- and (S)-TCA were then respectively synthesized by the cyclization of (R)- and (S)-ACS·HCI in ethanol in the presence of triethylamine.
